Figure 4.

Time‐matched QTcF vs plasma omarigliptin concentration (μM) from subjects in the single ascending dose study, with linear mixed‐effect model fit line.

Time‐matched QTcF vs plasma omarigliptin concentration (μM) from subjects in the single ascending dose study, with linear mixed‐effect model fit line.